Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 395895, 8 pages
http://dx.doi.org/10.1155/2015/395895
Research Article

Neuroprotective Effect of Sodium Butyrate against Cerebral Ischemia/Reperfusion Injury in Mice

1Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China
2Department of Neurology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China
3School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
4School of Environmental Science and Public Health, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

Received 12 February 2015; Accepted 24 April 2015

Academic Editor: Antoni Camins

Copyright © 2015 Jing Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. H. Danton and W. D. Dietrich, “Inflammatory mechanisms after ischemia and stroke,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 2, pp. 127–136, 2003. View at Google Scholar · View at Scopus
  2. T. J. Kleinig and R. Vink, “Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options,” Current Opinion in Neurology, vol. 22, no. 3, pp. 294–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Ashafaq, M. M. Khan, S. Shadab Raza et al., “S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia,” Nutrition Research, vol. 32, no. 2, pp. 133–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. H. Chan, “Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia,” Neurochemical Research, vol. 29, no. 11, pp. 1943–1949, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. H. Chan, “Role of oxidants in ischemic brain damage,” Stroke, vol. 27, no. 6, pp. 1124–1129, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pignataro, A. Scorziello, G. Di Renzo, and L. Annunziato, “Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy,” The FEBS Journal, vol. 276, no. 1, pp. 46–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Xia, J. Han, G. Huang, and W. Ying, “Inflammation in ischaemic brain injury: current advances and future perspectives,” Clinical and Experimental Pharmacology & Physiology, vol. 37, no. 2, pp. 253–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Brouns and P. P. de Deyn, “The complexity of neurobiological processes in acute ischemic stroke,” Clinical Neurology and Neurosurgery, vol. 111, no. 6, pp. 483–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. K. Mahajan, R. Kashyap, B. R. Sood et al., “Stroke at moderate altitude,” The Journal of Association of Physicians of India, vol. 52, pp. 699–702, 2004. View at Google Scholar · View at Scopus
  10. T. Liu, J. Li, Y. Liu et al., “Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-kappaB pathway in RAW264.7 cells,” Inflammation, vol. 35, no. 5, pp. 1676–1684, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D.-M. Chuang, Y. Leng, Z. Marinova, H.-J. Kim, and C.-T. Chiu, “Multiple roles of HDAC inhibition in neurodegenerative conditions,” Trends in Neurosciences, vol. 32, no. 11, pp. 591–601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Fischer, F. Sananbenesi, X. Wang, M. Dobbin, and L.-H. Tsai, “Recovery of learning and memory is associated with chromatin remodelling,” Nature, vol. 447, no. 7141, pp. 178–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. X. R. Hu, K. Zhang, C. W. Xu, Z. Q. Chen, and H. Jiang, “Anti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemia/reperfusion,” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 229–232, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Liang, R.-S. Wang, F. Wang et al., “Sodium butyrate protects against severe burn-induced remote acute lung injury in rats,” PLoS ONE, vol. 8, no. 7, Article ID e68786, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Yang, L. K. Wang, X. Li, L. W. Wang, X. Q. Han, and Z. J. Gong, “Sodium butyrate protects against toxin-induced acute liver failure in rats,” Hepatobiliary & Pancreatic Diseases International, vol. 13, no. 3, pp. 309–315, 2014. View at Google Scholar
  16. J. Zhu, Y. Jiang, L. Wu, T. Lu, G. Xu, and X. Liu, “Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia,” Neuroscience, vol. 202, pp. 342–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Moskowitz, K. J. Kiwak, K. Hekimian, and L. Levine, “Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion,” Science, vol. 224, no. 4651, pp. 886–889, 1984. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Zhao, R. Strong, J. Zhang et al., “Neuronal PPARγ deficiency increases susceptibility to brain damage after cerebral ischemia,” The Journal of Neuroscience, vol. 29, no. 19, pp. 6186–6195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Cipriani, P. Villa, G. Chece et al., “CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents,” The Journal of Neuroscience, vol. 31, no. 45, pp. 16327–16335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhai, X. Chen, J. Shi et al., “Lactulose ameliorates cerebral ischemia-reperfusion injury in ratsby inducing hydrogen by activating Nrf2 expression,” Free Radical Biology and Medicine, vol. 65, pp. 731–741, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Cao, X. Mao, C. Sun et al., “Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways,” Brain Research Bulletin, vol. 85, no. 6, pp. 396–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Li, Y. Qu, D. Chen et al., “The neuroprotective role and mechanisms of TERT in neurons with oxygen-glucose deprivation,” Neuroscience, vol. 252, pp. 346–358, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zhao, Y. Zhao, W. Zheng, Y. Lu, G. Feng, and S. Yu, “Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats,” Brain Research, vol. 1229, pp. 224–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Ricobaraza, M. Cuadrado-Tejedor, A. Pérez-Mediavilla, D. Frechilla, J. Del Río, and A. García-Osta, “Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an alzheimer's disease mouse model,” Neuropsychopharmacology, vol. 34, no. 7, pp. 1721–1732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. K. Hyeon, M. Rowe, M. Ren, J.-S. Hong, P.-S. Chen, and D.-M. Chuang, “Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action,” The Journal of Pharmacology and Experimental Therapeutics, vol. 321, no. 3, pp. 892–901, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H.-S. Suh, S. Choi, P. Khattar, N. Choi, and S. C. Lee, “Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes,” Journal of Neuroimmune Pharmacology, vol. 5, no. 4, pp. 521–532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ying, R. Xu, X. Wu et al., “Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA,” The Journal of Biological Chemistry, vol. 281, no. 18, pp. 12580–12586, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. S. I. Deutsch, R. B. Rosse, K. D. Long, B. L. Gaskins, J. A. Burket, and J. Mastropaolo, “Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801's pharmacologic action,” European Neuropsychopharmacology, vol. 18, no. 8, pp. 565–568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Rodrigo, A. P. Fernández, J. Serrano, M. A. Peinado, and A. Martínez, “The role of free radicals in cerebral hypoxia and ischemia,” Free Radical Biology & Medicine, vol. 39, no. 1, pp. 26–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Yamada, S. Yoshimura, H. Yamakawa et al., “Cell permeable ROS scavengers, Tiron and Tempol, rescue PC12 cell death caused by pyrogallol or hypoxia/reoxygenation,” Neuroscience Research, vol. 45, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, Y. Bao, B. Jiang et al., “Catalpol protects primary cultured astrocytes from in vitro ischemia-induced damage,” International Journal of Developmental Neuroscience, vol. 26, no. 3-4, pp. 309–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Gonçalves, I. Gregório, T. A. Catarino, and F. Martel, “The effect of oxidative stress upon the intestinal epithelial uptake of butyrate,” European Journal of Pharmacology, vol. 699, no. 1–3, pp. 88–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. B. R. S. Broughton, D. C. Reutens, and C. G. Sobey, “Apoptotic mechanisms after cerebral ischemia,” Stroke, vol. 40, no. 5, pp. e331–e339, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Vakili, S. Sharifat, M. M. Akhavan, and A. R. Bandegi, “Effect of lavender oil (Lavandula angustifolia) on cerebral edema and its possible mechanisms in an experimental model of stroke,” Brain Research, vol. 1548, pp. 56–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Béjot, A. Prigent-Tessier, C. Cachia et al., “Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats,” Neurochemistry International, vol. 58, no. 1, pp. 102–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Song, G. Ouyang, and S. Bao, “The activation of Akt/PKB signaling pathway and cell survival,” Journal of Cellular and Molecular Medicine, vol. 9, no. 1, pp. 59–71, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Bozlu, A. Atici, A. H. Turhan et al., “Platelet-activating factor antagonist (ABT-491) decreases neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury,” Brain Research, vol. 1143, pp. 193–198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zhou, T. Lekic, N. Fathali et al., “Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/akt pathway,” Stroke, vol. 41, no. 7, pp. 1521–1527, 2010. View at Publisher · View at Google Scholar · View at Scopus